Equities analysts expect AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) to report sales of $40.28 billion for the current quarter, Zacks reports. Five analysts have made estimates for AmerisourceBergen Corporation (Holding Co)’s earnings, with the highest sales estimate coming in at $40.91 billion and the lowest estimate coming in at $39.65 billion. AmerisourceBergen Corporation (Holding Co) posted sales of $37.56 billion in the same quarter last year, which suggests a positive year over year growth rate of 7.2%. The company is expected to issue its next earnings report on Wednesday, November 1st.

On average, analysts expect that AmerisourceBergen Corporation (Holding Co) will report full-year sales of $40.28 billion for the current year, with estimates ranging from $153.67 billion to $155.35 billion. For the next financial year, analysts anticipate that the business will post sales of $166.40 billion per share, with estimates ranging from $163.64 billion to $168.67 billion. Zacks’ sales averages are an average based on a survey of research analysts that that provide coverage for AmerisourceBergen Corporation (Holding Co).

AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $1.43 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.37 by $0.06. AmerisourceBergen Corporation (Holding Co) had a return on equity of 56.07% and a net margin of 0.56%. The company had revenue of $38.71 billion during the quarter, compared to analyst estimates of $39.13 billion. During the same quarter in the previous year, the firm earned $1.37 earnings per share. AmerisourceBergen Corporation (Holding Co)’s revenue was up 4.9% on a year-over-year basis.

Several research analysts have recently commented on ABC shares. Vetr raised AmerisourceBergen Corporation (Holding Co) from a “buy” rating to a “strong-buy” rating and set a $97.44 price objective on the stock in a research note on Tuesday, April 18th. Mizuho raised their price objective on AmerisourceBergen Corporation (Holding Co) from $83.00 to $93.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 30th. BidaskClub raised AmerisourceBergen Corporation (Holding Co) from a “hold” rating to a “buy” rating in a research note on Saturday, June 17th. Jefferies Group LLC started coverage on AmerisourceBergen Corporation (Holding Co) in a research note on Wednesday, May 17th. They issued a “hold” rating and a $95.00 price objective on the stock. Finally, Zacks Investment Research downgraded AmerisourceBergen Corporation (Holding Co) from a “hold” rating to a “sell” rating in a research note on Monday, July 10th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $93.14.

ILLEGAL ACTIVITY NOTICE: “Analysts Expect AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) Will Announce Quarterly Sales of $40.28 Billion” was posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/08/08/analysts-expect-amerisourcebergen-corporation-holding-co-nyseabc-will-announce-quarterly-sales-of-40-28-billion.html.

In other AmerisourceBergen Corporation (Holding Co) news, Chairman Steven H. Collis sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $94.76, for a total transaction of $1,421,400.00. Following the completion of the transaction, the chairman now owns 253,876 shares in the company, valued at approximately $24,057,289.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 27.40% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the stock. Parallel Advisors LLC boosted its position in AmerisourceBergen Corporation (Holding Co) by 3.2% in the second quarter. Parallel Advisors LLC now owns 1,109 shares of the company’s stock valued at $104,000 after buying an additional 34 shares in the last quarter. Point72 Asia Hong Kong Ltd purchased a new position in AmerisourceBergen Corporation (Holding Co) during the first quarter valued at $105,000. American Beacon Advisors Inc. purchased a new position in AmerisourceBergen Corporation (Holding Co) during the first quarter valued at $108,000. SRS Capital Advisors Inc. boosted its position in AmerisourceBergen Corporation (Holding Co) by 0.3% in the first quarter. SRS Capital Advisors Inc. now owns 1,235 shares of the company’s stock valued at $109,000 after buying an additional 4 shares in the last quarter. Finally, ClariVest Asset Management LLC purchased a new position in AmerisourceBergen Corporation (Holding Co) during the first quarter valued at $143,000. Institutional investors and hedge funds own 68.87% of the company’s stock.

AmerisourceBergen Corporation (NYSE ABC) opened at 80.58 on Tuesday. The stock’s 50 day moving average price is $93.75 and its 200 day moving average price is $89.47. AmerisourceBergen Corporation has a one year low of $68.38 and a one year high of $97.85. The stock has a market cap of $17.60 billion, a price-to-earnings ratio of 15.64 and a beta of 0.91.

AmerisourceBergen Corporation (Holding Co) Company Profile

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Get a free copy of the Zacks research report on AmerisourceBergen Corporation (Holding Co) (ABC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for AmerisourceBergen Corporation (Holding Co) (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Corporation (Holding Co) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corporation (Holding Co) and related companies with MarketBeat.com's FREE daily email newsletter.